
CHEXF
Other · Other · $15.3M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jan 31, 2019 | Time not confirmed | — | -0.03 | — |
| Oct 31, 2018 | Time not confirmed | — | -0.04 | — |
| Jul 31, 2018 | Time not confirmed | — | -0.02 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.02 | — |
| Jan 31, 2018 | Time not confirmed | — | -0.03 | — |
Avivagen Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defenses. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. The company was formerly known as…